Satellos Bioscience Inc. (MSCL)

Profile

https://satellos.com

Satellos Bioscience Inc. is a clinical-stage biotechnology company focused on developing therapies for degenerative muscle diseases. Satellos Bioscience Inc. works in regenerative medicine, using its proprietary MyoReGenX platform to study muscle stem cell biology and identify approaches that may restore the body’s natural ability to repair muscle. The company’s current efforts center on small-molecule therapeutics, including programs aimed at Duchenne muscular dystrophy and other serious neuromuscular disorders. Its work is directed at improving treatment options in a field with significant unmet medical need, where muscle regeneration and function are central to patient care. Based in Toronto, Satellos Bioscience Inc. operates as a research-driven drug development company within the broader biotechnology and healthcare markets.